Share

AstraZeneca (AZN) Stock Higher, Jefferies Upgrades

On Monday Citigroup upgraded its broker consensus on shares of Man Group PLC (LON:EMG) giving the company a “Buy” rating. Jefferies International have set their target price at 5800 GBX on its stock. Vetr’s target price suggests a potential upside of 12.27% from the stock’s previous close.

Advertisement

BP has been the topic of several other research reports. The investment management company now holds a total of 141,550 shares of XL Group plc which is valued at $4,719,277 after selling 20,520 shares in XL Group plc, the firm said in a disclosure report filed with the SEC on Aug 15, 2016.XL Group plc makes up approximately 3.43% of Breithorn Capital Management’s portfolio. Finally, Beaufort Securities reissued a “hold” rating on shares of Astrazeneca PLC in a report on Thursday, August 11th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating, eleven have given a buy rating and three have issued a strong buy rating to the stock. The company now has a consensus rating of “Buy” and a consensus price target of $38.55.

Shares of Astrazeneca PLC (NYSE:AZN) opened at 32.20 on Monday.

Hikma Pharmaceuticals PLC has a 52 week low of 1,575.00GBX and a 52 week high of 2,703.00GBX with a PE ratio of 26. Market capitalisation for LON:AZN is £60,909,705,718 GBP.

AstraZeneca plc LON:AZN has a 50 day moving average of 4,923.71 GBX and the 200 Day Moving Average price is recorded at 4,371.76 GBX. Analyst had a consensus estimate of $0.83. Astrazeneca PLC had a net margin of 9.23% and a return on equity of 28.02%. The firm earned $2.72 billion during the quarter, compared to analyst estimates of $2.40 billion. During the same quarter in the prior year, the company posted $1.21 earnings per share. The business’s revenue for the quarter was down 25.7% on a year-over-year basis. There are now 1,268,027,599 shares in issue with the average daily volume traded being 2,480,455. The ex-dividend date of this dividend is Tuesday, September 13th. BP PLC’s dividend payout ratio is now -139.18%.

Advertisement

A number of large investors recently modified their holdings of the company. Iowa State Bank acquired a new stake in BP PLC during the second quarter valued at $159,000. Primecap Management Co. CA increased its position in Astrazeneca PLC by 1,223.1% in the first quarter. Pioneer Investment Management Inc. now owns 2,201,690 shares of the company’s stock valued at $74,747,000 after buying an additional 679,014 shares during the last quarter. Finally, Commonwealth Financial Services LLC boosted its stake in BP PLC by 6.1% in the second quarter. Checchi Capital Advisers LLC now owns 3,045 shares of the company’s stock valued at $101,000 after buying an additional 33 shares in the last quarter.

Hikma Pharmaceuticals PLC